Navigation Links
Neurovascular/Interventional Neurology Market: Global Trends & Competitive Analysis - 2017
Date:2/21/2013

(PRWEB) February 21, 2013

Research and Markets announces the addition of, "Neurovascular/Interventional Neurology Market: Global Trends & Competitive Analysis - 2017", to their offering.

Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasive procedures to diagnose and treat vascular disorders of the brain and spine. With the help of advanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tiny tubes) to treat many complex disorders. Normally these disorders are treated either by closing (embolization) or opening (recanalization) the abnormal vessels. The neurointerventional device market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

This research on neurointerventional devices market, "Neurovascular/Interventional Neurology Market: Global Trends & Competitive Analysis - 2017", encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of the global neurointerventional devices market, followed by support devices cerebral balloon angioplasty & stenting systems and neurothrombectomy devices in 2012.

The major driving factor for these markets involves gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America dominates the overall neurointerventional devices market. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and Latin American market.

Companies mentioned include Abbott Laboratories, Bayer Ag, Coaxia, Inc., Covidien Plc, Johnson & Johnson, Merit Medical Systems Inc., Neurointerventional Therapeutics Inc. (Nit), Nfocus Neuromedical Inc., Penumbra Inc., Reverse Medical Corporation, Stryker Corporation, Terumo Corporation, Valor Medical Inc., W.L.Gore & Associates Inc.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Neurointerventional Devices Market, By Techniques

5 Global Neurointerventional Devices Market, By Products

6 Geographic Analysis

7 Competitive Landscape

8 Company Profiles

For more information please go to http://www.researchandmarkets.com/research/5h6mw6/neurovascularinte

Research and Markets
Laura Wood, Senior Manager.
Email: press(at)researchandmarkets(dot)com
Phone: +35314151241

Sectore: Healthcare and Medical

Read the full story at http://www.prweb.com/releases/2013/2/prweb10455036.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. France & Germany Blood Banking Market: Innovative Technologies and Emerging Business Opportunities in New Research Report at ReportsnReports.com
2. Life Technologies to Present at Barclays Global Healthcare Conference
3. GoLIMS Technology Speeds and Safeguards Alltechs Global Research
4. Foot & Ankle Devices Market (2012 – 2017) By Product Type (External Fixation, Internal Fixation, Joint Replacement, Prosthesis, Bracing) - Global Trends & Competitive Analysis
5. Interventional Cardiology Devices Market is Expected to Reach USD 25.2 Billion Globally in 2018: Transparency Market Research
6. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
7. Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
8. INRS researchers at the Global Young Academy
9. Trovagene to Present at Leerink Swan Global Healthcare Conference
10. Injection-free vaccination technique could address global vaccine challenge for HIV, malaria
11. Honble Prime Minister Dr. Manmohan Singh Inaugurates TERIs Delhi Sustainable Development Summit (DSDS) 2013 on Global Challenge of Resource-Efficient Growth and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... LAFAYETTE, Indiana (PRWEB) , ... ... ... division of Albany Molecular Research Inc. has further extended its industry leading ... This service offers state-of-the-art cGMP techniques and methods for the ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... -- A new independent identity strategy consultancy firm announces ... Designed to fill a critical niche in technical and ... Mark Crego and Janice Kephart ... expertise that span federal governments, the 9/11 Commission, private ... expertise has a common theme born from a shared ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
Breaking Biology News(10 mins):